Last €74.33 EUR
Change Today 0.00 / 0.00%
Volume 0.0
As of 3:17 AM 05/17/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Helen I. Torley M.B. Ch. B., M.R.C.P.

Chief Commercial officer and Executive Vice President, Onyx Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

49--
As of Fiscal Year 2011

Background*

Dr. Helen I. Torley, M.B. Ch. B., M.R.C.P. has been the Chief Commercial Officer and Executive Vice President of Onyx Pharmaceuticals, Inc. since August 29, 2011. Dr. Torley served as Vice President and General Manager of Nephrology Business Unit at Amgen Inc. since October 2003. She joined Amgen Inc. on June 2002 as Therapeutic Area Head of Inflammation Global Marketing. She serves as the Chief Commercial Officer and Executive Vice President at Onyx Pharmaceuticals ...

Read Full Background

Corporate Headquarters*

249 East Grand Avenue
South San Francisco, California 94080

United States

Phone: 650-266-0000
Fax: 650-266-0100

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Unknown/Other Education 1984
University of Glasgow Scotland

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OX1:GR €74.33 EUR 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman and Chief Executive Officer
Alkermes plc
$775.0K
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$821.1K
Robert W. Duggan Chairman and Chief Executive Officer
Pharmacyclics Inc.
--
Paul A. Friedman M.D.Chief Executive Officer, President, Director, Member of Non-Management Stock Option Committee and Member of Finance Committee
Incyte Corporation
$666.5K
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$722.2K
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ONYX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.